Rady A. Johnson - 12 Sep 2024 Form 4 Insider Report for PFIZER INC (PFE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Sep 2024, 13:06:10 UTC
Prior SEC filing
03 Sep 2024
Next SEC filing
02 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Susan E. Grant, by power of atty., for Rady A. Johnson

Key filing fact

Rady A. Johnson filed Form 4 for PFIZER INC (PFE) on 16 Sep 2024.

Key facts

  • This page summarizes Rady A. Johnson's Form 4 filing for PFIZER INC (PFE).
  • 5 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 16 Sep 2024, 13:06.

Change

  • Previous filing in this sequence was filed on 03 Sep 2024.
  • Current net transaction value: +$176.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PFE transaction Derivative

Stock Appreciation Rights

Disposed to Issuer

Transaction value
$0
Shares
-24,797
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Sep 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,797
Exercise price
$42.30
Footnotes
F1
PFE transaction Derivative

Stock Appreciation Rights

Award

Transaction value
$0
Shares
+24,797
Change %
Price
$0.000000
Shares after
24,797
Date
12 Sep 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,797
Exercise price
$42.30
Footnotes
F1, F2
PFE transaction Derivative

Stock Appreciation Rights

Disposed to Issuer

Transaction value
$0
Shares
-22,823
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Sep 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
22,823
Exercise price
$45.96
Footnotes
F1
PFE transaction Derivative

Stock Appreciation Rights

Award

Transaction value
$0
Shares
+22,823
Change %
Price
$0.000000
Shares after
22,823
Date
12 Sep 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
22,823
Exercise price
$45.96
Footnotes
F1, F2
PFE transaction Derivative

Phantom Stock Units SSP

Award

Transaction value
$176
Shares
+6
Change %
+0.07%
Price
$29.27
Shares after
9,148
Date
13 Sep 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged.

Footnote F2

Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged.

Footnote F3

Each unit represents one phantom share of common stock.

Footnote F4

These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .